The Nobel discovery: cells that feel force
Ardem Patapoutian was awarded the 2021 Nobel Prize in Physiology or Medicine jointly with David Julius for the discovery of TRPV1 (heat and capsaicin) and, in Patapoutian’s case, Piezo1 and Piezo2 — the molecular basis of mechanosensation. The question of how cells sense mechanical force — touch, pressure, shear, stretch — had been open for decades. Patch-clamp electrophysiology had shown that mechanically activated ion channels existed, but identifying the underlying proteins proved elusive.
The Patapoutian lab’s approach was systematic. They used a cell line known to show mechanically activated currents (F11 cells), silenced candidate membrane protein genes one by one using siRNA, and used a pressure-sensitive electrode to measure when mechanosensitive currents disappeared. Two genes stood out: FAM38A and FAM38B, renamed Piezo1 and Piezo2 after the Greek word for pressure (piezein). Both are large trimeric membrane proteins — each subunit is around 2,500 amino acids, making them among the largest ion channels known — that form a propeller-shaped structure embedded in the plasma membrane. When the membrane is deformed by mechanical force, the channels open, admitting primarily calcium ions.
Piezo1 in red blood cells: volume regulation and xerocytosis
Red blood cells are unusual among cells in having no nucleus and no transcriptional capacity. They cannot upregulate protein expression in response to stress. They are mechanically extreme objects — a 7–8 micrometre biconcave disc forced to deform repeatedly through capillaries as narrow as 3 micrometres during a 120-day lifespan. This mechanical stress places extraordinary demands on the cell’s cytoskeleton and volume regulation machinery.
Piezo1 is expressed in erythrocytes and plays a role in volume regulation. When Piezo1 is activated — by the mechanical stress of capillary transit, for example — calcium enters the cell. Elevated intracellular calcium activates the Gardos channel (KCNN4), a calcium-activated potassium channel. Potassium efflux through the Gardos channel drives osmotic water loss, shrinking the cell. This is a controlled dehydration mechanism, important for maintaining the optimal surface-to-volume ratio that allows extreme deformability.
Gain-of-function mutations in Piezo1 cause hereditary xerocytosis (also called dehydrated hereditary stomatocytosis), a rare haemolytic anaemia in which erythrocytes are chronically dehydrated. The overactive Piezo1 channel drives excessive Gardos channel activation, excessive water loss, and cell shrinkage — producing cells that are fragile and prone to haemolysis. Conversely, loss-of-function Piezo1 mutations produce a different phenotype characterised by overhydrated cells and haemolytic anaemia.
A population genetics study published in Nature by Gurarie, Flint, and colleagues found that a Piezo1 E756del variant — a gain-of-function variant that causes mild erythrocyte dehydration — is common in populations with historical malaria exposure in sub-Saharan Africa, reaching allele frequencies above 30% in some populations. Mildly dehydrated erythrocytes appear to be somewhat resistant to Plasmodium falciparum invasion, suggesting the variant conferred a survival advantage in malaria-endemic environments. This is one of the strongest examples of ongoing human evolution in response to an infectious disease.
Piezo1 in vascular endothelium: shear stress and eNOS activation
The vascular endothelium is continuously subjected to fluid shear stress from blood flow. The endothelium senses shear and converts it into intracellular signals that regulate vascular tone, inflammatory activation, and structural remodelling — a process called mechanotransduction. Piezo1 is a major shear stress sensor in endothelial cells.
When blood flow increases and shear stress rises, endothelial Piezo1 channels open, admitting calcium. The calcium influx activates endothelial nitric oxide synthase (eNOS) through multiple mechanisms: direct calmodulin activation, and phosphorylation of eNOS at Ser1177 via the calcium/calmodulin-dependent protein kinase (CaMKII) pathway. eNOS generates nitric oxide (NO) from L-arginine, and NO diffuses into adjacent smooth muscle cells where it activates soluble guanylate cyclase, raises cyclic GMP, and drives vasodilation through myosin light chain dephosphorylation.
This Piezo1 → calcium → eNOS → NO → cGMP → vasodilation cascade is one of the primary mechanisms by which exercise-induced increases in cardiac output cause appropriate vasodilation — matching oxygen delivery to metabolic demand. It is also the mechanism relevant to resting blood pressure: endothelial Piezo1 activity contributes to basal NO production and therefore to basal vascular tone.
A landmark 2018 paper by Li and colleagues in eLifeshowed that endothelial-specific deletion of Piezo1 in mice resulted in impaired flow-induced vasodilation and elevated blood pressure, directly confirming the channel’s role in blood pressure regulation. Conversely, pharmacological activation of Piezo1 using the small molecule agonist Yoda1 induces calcium entry and NO production in endothelial cells.
Connecting to spirulina: iron, haematology, and RBC effects
Spirulina is a significant dietary source of non-haem iron — approximately 2–3 mg per gram of dried spirulina, though bioavailability is subject to the usual caveats about non-haem iron absorption (enhanced by vitamin C, inhibited by phytates and tannins). Several controlled trials in iron-deficient populations have shown spirulina supplementation improves haematological markers: haemoglobin, haematocrit, mean corpuscular haemoglobin (MCH), and serum ferritin.
The relevance to Piezo1 is indirect but real. Iron-deficiency anaemia produces a compensatory increase in erythropoiesis (new RBC production) and changes in RBC properties — including mean corpuscular volume (MCV) — that affect how cells interact with the vasculature. More directly, when anaemia resolves through iron repletion, the population of circulating erythrocytes changes: older, more deformed cells are replaced by younger reticulocytes that are more deformable and mechanically compliant. The mechanical properties of the erythrocyte pool influence how Piezo1 is activated during capillary transit — younger, healthier cells require less mechanical force to deform, meaning the calcium entry profile differs from that of dehydrated, rigid cells.
This is not a direct Piezo1 study on spirulina — none exist. But the chain from spirulina to iron status to erythrocyte health to Piezo1 activation dynamics is mechanistically coherent.
Phycocyanin, eNOS, and the blood pressure connection
The spirulina-Piezo1-eNOS connection is perhaps most direct in the context of blood pressure. Several clinical trials have shown spirulina supplementation modestly reduces systolic and diastolic blood pressure in hypertensive subjects. The most commonly proposed mechanism involves phycocyanin’s effects on eNOS and NO bioavailability.
Phycocyanin has been shown in in vitro and animal studies to increase eNOS expression and activity, increase NO production, reduce ROS levels (ROS rapidly quench NO, so reducing ROS extends NO half-life), and reduce the production of endothelin-1 — the endogenous vasoconstrictive peptide that counterbalances NO.
The Piezo1 relevance here is that Piezo1-driven calcium entry is one of the inputs to eNOS activation. If phycocyanin enhances eNOS expression at the baseline level — increasing eNOS protein abundance — then the downstream vasodilatory response to Piezo1 activation would be amplified. In other words, phycocyanin and Piezo1 may converge on the same effector (eNOS) from different directions: Piezo1 providing the calcium signal, phycocyanin increasing the enzyme capacity. The downstream effect — more NO, lower vascular tone — would be the same regardless of which input is rate-limiting.
Piezo1 in macrophages and immune function
Beyond red blood cells and endothelium, Piezo1 is expressed in macrophages and plays a role in their inflammatory activation. A 2018 study by Atkinson and colleagues in Nature Communications showed that Piezo1 activation in macrophages stimulates phagocytosis and inflammatory cytokine production. The calcium entry through Piezo1 activates downstream inflammatory signalling pathways including calcineurin/NFAT.
Macrophages in inflamed tissues encounter altered mechanical environments — oedematous tissue is stiffer, fibrous tissue from chronic inflammation changes extracellular matrix mechanics. Piezo1-mediated mechanosensing allows macrophages to detect these physical cues and adjust their activation state accordingly.
The connection to spirulina here is through phycocyanin’s well-established immunomodulatory effects. Phycocyanin reduces macrophage NF-κB activation, lowers IL-1β, IL-6, and TNF-α production, and in some studies promotes an anti-inflammatory M2-like polarisation. Whether these effects intersect specifically with Piezo1-mediated macrophage activation is unknown — but the downstream targets (cytokine production, inflammatory signalling) overlap substantially.
Piezo1 variants and population-level differences in spirulina response
The high frequency of the E756del Piezo1 variant in populations of West African ancestry raises an interesting population-medicine question. This variant produces constitutively slightly more active Piezo1 — erythrocytes are mildly dehydrated, and the endothelial shear-sensing response may also be altered. If spirulina’s haematological and vascular effects partially operate through mechanisms that intersect with Piezo1 function, individuals carrying the E756del variant might show different response profiles.
No study has examined spirulina supplementation stratified by Piezo1 genotype. Given that the most commonly studied populations for spirulina’s iron effects are in sub-Saharan Africa — where the E756del variant is common — this is not an entirely academic point. It illustrates how population genetic variation in mechanosensitive channels can be relevant even when the primary interest is a dietary supplement.
Summary and honest limits
Piezo1 is a mechanosensitive calcium channel with established roles in red blood cell volume regulation, endothelial shear sensing and vasodilation, and macrophage inflammatory activation. The Nobel Prize recognition in 2021 reflects how fundamental this biology is.
Spirulina’s haematological effects (via iron), blood pressure effects (via phycocyanin and eNOS), and immunomodulatory effects (via phycocyanin and macrophage signalling) each touch systems that Piezo1 also regulates. The honest assessment is that the overlap is mechanistically real but has not been studied directly. No published study has examined spirulina’s effects on Piezo1 expression, activity, or downstream calcium signalling specifically. The connection is a framework for understanding how spirulina’s diverse physiological effects might converge — not a proven mechanism.